Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Journal of Clinical Surgery ; (12): 698-700, 2017.
Article in Chinese | WPRIM | ID: wpr-662548

ABSTRACT

Objective To evaluate the clinical effects of bladder perfusion combined with deep hyperthermia on preventing postoperative recurrence of non-muscle invasive bladder cancer.Methods Choose 98 patients with NMIBC who were treated with transurethral bladder cancer resection,and randomly divide them into two groups,research group and control group,49 cases in each.Giving MMC bladder perfusion chemotherapy to the control group,and added deep hyperthermia to the research group on the basis of bladder peffusion.Contrast the relapse rates and condition of adverse events during treatment.Resnits The relapse rates of research group when treatment was continued for 6,9,12,15,18 months were significantly lower than that of control group(4.08% VS 10.20%,6.12% VS 12.24%,10.20% VS 18.37%,10.20% VS 20.41%,14.29% VS 24.50%,all P < 0.05).No statistical significance in adverse events between each group was observed (P > 0.05).Conclusion MMC bladder perfusion combined with deep hyperthermia therapy has great clinical value,as it can reduce the rates of postoperative recurrence of NMIBC,as well as not increase the AEs of bladder perfusion.

2.
Journal of Clinical Surgery ; (12): 698-700, 2017.
Article in Chinese | WPRIM | ID: wpr-660265

ABSTRACT

Objective To evaluate the clinical effects of bladder perfusion combined with deep hyperthermia on preventing postoperative recurrence of non-muscle invasive bladder cancer.Methods Choose 98 patients with NMIBC who were treated with transurethral bladder cancer resection,and randomly divide them into two groups,research group and control group,49 cases in each.Giving MMC bladder perfusion chemotherapy to the control group,and added deep hyperthermia to the research group on the basis of bladder peffusion.Contrast the relapse rates and condition of adverse events during treatment.Resnits The relapse rates of research group when treatment was continued for 6,9,12,15,18 months were significantly lower than that of control group(4.08% VS 10.20%,6.12% VS 12.24%,10.20% VS 18.37%,10.20% VS 20.41%,14.29% VS 24.50%,all P < 0.05).No statistical significance in adverse events between each group was observed (P > 0.05).Conclusion MMC bladder perfusion combined with deep hyperthermia therapy has great clinical value,as it can reduce the rates of postoperative recurrence of NMIBC,as well as not increase the AEs of bladder perfusion.

SELECTION OF CITATIONS
SEARCH DETAIL